Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation

American Journal of Sports Medicine

Volumn 41, Issue 4, 2013, Pages 908-917

  Attia, Mohamed ^a,b   Huet, Eric ^a   Gossard, Camille ^b   Menashi, Suzanne ^a   Tassoni, Marie Claude ^b,c   Martelly, Isabelle ^a  

^a Université Paris Est Créteil ^*  (France)

^b Département de Mecanobiologie   (France)

^c Osteobio   (France)

Author keywords

EMMPRIN; inflammation process; MMPs; overuse; supraspinatus tendon

Indexed keywords

CD147 ANTIGEN; COLLAGENASE 3; GELATINASE; GELATINASE A; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL; ARTICLE; ENZYMOLOGY; EXTRACELLULAR MATRIX; INFLAMMATION; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; RAT; SPRAGUE DAWLEY RAT; TENDINITIS; TENDON; UPREGULATION;

ANIMALS; ANTIGENS, CD147; EXTRACELLULAR MATRIX; GELATINASES; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; TENDINOPATHY; TENDONS; UP-REGULATION;

EID: 84875856859     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546512473817     Document Type: Article

References (31)

1. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995 ; 270 (11). 5872-5876
2. Alfredson H, Lorentzon M, Backman S, Backman A, Lerner UH. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res. 2003 ; 21 (6). 970-975 (Pubitemid 37322376)
3. Attia M, Scott A, Duchesnay A, et al. Alterations of overused supraspinatus tendon: a possible role of glycosaminoglycans and HARP/pleiotrophin in early tendon pathology. J Orthop Res. 2012 ; 30 (1). 61-71
4. Corps AN, Robinson AH, Harrall RL, et al. Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy. Ann Rheum Dis. 2012 ; 71 (5). 746-752
5. De Mello Malheiro OC, Giacomini CT, Justulin LA, Delella FK, Dal-Pai-Silva M, Felisbino SL. Calcaneal tendon regions exhibit different MMP-2 activation after vertical jumping and treadmill running. Anat Rec (Hoboken). 2009 ; 292 (10). 1656-1662
6. de Mos M, van El B, DeGroot J, et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med. 2007 ; 35 (9). 1549-1556 (Pubitemid 47301088)
7. Del Buono A, Battery L, Denaro V, Maccauro G, Maffulli N. Tendinopathy and inflammation: some truths. Int J Immunopathol Pharmacol. 2011 ; 24: 45-50
8. Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res. 2006 ; 69 (3). 625-635 (Pubitemid 43139725)
9. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem. 2001 ; 276 (27). 24833-24842
10. Fridman R, Toth M, Pena D, Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 1995 ; 55 (12). 2548-2555
11. Fu SC, Chan BP, Wang W, Pau HM, Chan KM, Rolf CG. Increased expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis. Acta Orthop Scand. 2002 ; 73 (6). 658-662 (Pubitemid 36020909)
12. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005 ; 87 (3-4). 361-368 (Pubitemid 40387615)
13. Haseneen NA, Vaday GG, Zucker S, Foda HD. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. Am J Physiol Lung Cell Mol Physiol. 2003 ; 284 (3). L541 - L547
14. Huet E, Gabison EE, Mourah S, Menashi S. Role of EMMPRIN/CD147 in tissue remodeling. Connect Tissue Res. 2008 ; 49 (3). 175-179
15. Ireland D, Harrall R, Curry V, et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol. 2001 ; 20 (3). 159-169 (Pubitemid 32564929)
16. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum. 2006 ; 54 (3). 832-842
17. Lo IK, Marchuk LL, Hollinshead R, Hart DA, Frank CB. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med. 2004 ; 32 (5). 1223-1229 (Pubitemid 38970376)
18. Neviaser A, Andarawis-Puri N, Flatow E. Basic mechanisms of tendon fatigue damage. J Shoulder Elbow Surg. 2012 ; 21 (2). 158-163
19. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997 ; 272 (4). 2446-2451 (Pubitemid 27058534)
20. Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem. 1997 ; 244 (1). 161-166 (Pubitemid 27030540)
21. RasbandWS. ImageJ. Bestheda, Maryland: National Institutes of Health; 1997-2009. http://imagej.nih.gov/ij/. Accessed January 14, 2013.
22. Riley G. The pathogenesis of tendinopathy: a molecular perspective. Rheumatology (Oxford). 2004 ; 43 (2). 131-142
23. Riley G. Symposium: tendon and ligament remodelling and regeneration. Int J Exp Pathol. 2007 ; 88 (4). 215-216 (Pubitemid 47256313)
24. Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol. 2002 ; 21 (2). 185-195 (Pubitemid 34145243)
25. Saupe N, Pfirrmann CW, Schmid MR, Jost B, Werner CM, Zanetti M. Association between rotator cuff abnormalities and reduced acromiohumeral distance. AJR Am J Roentgenol. 2006 ; 187 (2). 376-382 (Pubitemid 44148280)
26. Seltzre JL, Eisen AZ. Native type I collagen is not a substrate for MMP2 (gelatinase A). J Invest Dermatol. 1999 ; 112 (6). 993-994 (Pubitemid 29278006)
27. Sharma P, Maffulli N. Tendinopathy and tendon injury: the future. Disabil Rehabil. 2008 ; 30 (20-22). 1733-1745
28. Sier CF, Zuidwijk K, Zijlmans HJ, et al. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma. Int J Cancer. 2006 ; 118 (12). 2991-2998
29. Soslowsky LJ, Carpenter JE, DeBano CM, Banerji I, Moalli MR. Development and use of an animal model for investigations on rotator cuff disease. J Shoulder Elbow Surg. 1996 ; 5 (5). 383-392
30. Soslowsky LJ, Thomopoulos S, Tun S, et al. Neer Award 1999. Overuse activity injures the supraspinatus tendon in an animal model: a histologic and biomechanical study. J Shoulder Elbow Surg. 2000 ; 9 (2). 79-84
31. Wu JJ, Weis MA, Kim LS, Eyre DR. Type III collagen, a fibril network modifier in articular cartilage. J Biol Chem. 2010 ; 285 (24). 18537-18544